Breaking News Instant updates and real-time market news.

TEVA

Teva

$37.86

-0.29 (-0.76%)

08:09
11/30/16
11/30
08:09
11/30/16
08:09

Teva to present data on Granix, Treanda, Trisenox injections at ASH meeting

Teva announced that data on GRANIX Injection, TREANDA Injection and TRISENOX Injection will be presented during poster sessions at the 2016 ASH Annual Meeting to be held at the San Diego Convention Center in San Diego, CA on December 3-6, 2016. Additional bendamustine abstracts were also accepted for publication in an online issue of Blood to be issued during the annual meeting. "We look forward to sharing real world data and outcomes research from our Oncology portfolio that provide deeper insights into our products," said Richard Nieman, M.D., SVP, Global Medical Affairs, Teva Pharmaceuticals. "The presentations at this year's ASH Meeting further highlight Teva's commitment to providing innovative medicines that positively impact our healthcare system, treatment and management of disease, and the lives of people, particularly those affected by cancer."

  • 03

    Apr

TEVA Teva
$37.86

-0.29 (-0.76%)

11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MAXM
11/17/16
NO CHANGE
Target $52
MAXM
Buy
Teva price target lowered to $52 from $72 at Maxim
Maxim analyst Gabrielle Zhou lowered her price target for Teva to $52 from $72 after the company reported Q3 results and cut it full-year guidance. The analyst notes that the company has started its Actavis integration, with the latter now contributing to Teva's generic revenues. However, she believes Teva needs to focus now on growth, noting that 2017 will be a challenge. Zhou reiterates a Buy rating on Teva's shares.
11/22/16
LEER
11/22/16
NO CHANGE
LEER
Outperform
Alder Biopharmaceuticals patent fight far from over, says Leerink
Leerink analyst Joseph Schwartz says Alder Biopharmaceuticals (ALDR) stated that the European Patent Office issued a ruling revoking all claims in its competitor Teva's (TEVA) patent relating to CGRP antagonist antibodies but maintaining and narrowing claims relating to the use of CGRP antagonist antibodies in human therapy to the prevention or treatment of headache such as migraine and cluster headache. The analyst notes that the persistence of the headache claims has concerned investors, but points out that Alder believes the patent fight is far from over in the EU, or moreover in the U.S. Schwartz reiterates an Outperform rating on Alder's shares.
11/25/16
PIPR
11/25/16
NO CHANGE
Target $47
PIPR
Overweight
Alder recent selloff an overreaction, says Piper Jaffray
Piper Jaffray analyst Charles Duncan attributes the recent weakness in shares of Alder Biopharmaceuticals (ALDR) to "increased visibility and outcome uncertainty" for the company's challenge to Teva's (TEVA) anti-CGRP patents in the U.S. and Europe. The analyst views the selloff as an overreaction and remains focused on his "clinical data-driven thesis for the emerging, differentiated profile of lead candidate ALD403." Duncan keeps an Overweight rating on Alder with a $47 price target.

TODAY'S FREE FLY STORIES

15:42
02/23/17
02/23
15:42
02/23/17
15:42
Conference/Events
UBS banking analysts hold an analyst/industry conference call »

Large Cap Banks Analyst…

HGG

hhgregg

$0.45

0.0142 (3.26%)

15:39
02/23/17
02/23
15:39
02/23/17
15:39
Periodicals
hhgregg said to prepare bankruptcy filing as early as March, Bloomberg says »

Bloomberg added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$72.14

0.43 (0.60%)

, TGT

Target

$65.62

-0.32 (-0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Periodicals
Trump supportive of border tax in Reuters interview »

Headlines crossing…

WMT

Wal-Mart

$72.14

0.43 (0.60%)

TGT

Target

$65.62

-0.32 (-0.49%)

HD

Home Depot

$145.17

-0.081 (-0.06%)

LOW

Lowe's

$76.40

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

OLED

Universal Display

$71.25

-0.3 (-0.42%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Options
Universal Display options imply 12.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story  »

Harmony Merger trading…

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story on Harmony Merger Corp. »

Harmony Merger Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORI

Old Republic

$20.95

-0.07 (-0.33%)

15:27
02/23/17
02/23
15:27
02/23/17
15:27
Hot Stocks
Old Republic raises dividend, extends shareholder rights plan, expands board »

Old Republic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.46

-0.12 (-1.40%)

15:26
02/23/17
02/23
15:26
02/23/17
15:26
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$5.73

0.06 (1.06%)

15:24
02/23/17
02/23
15:24
02/23/17
15:24
Recommendations
TherapeuticsMD analyst commentary  »

TherapeuticsMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

  • 21

    Mar

  • 07

    May

USB

U.S. Bancorp

$55.38

0.07 (0.13%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Periodicals
Trump considers outgoing U.S. Bancorp CEO for Fed board seat, Bloomberg says »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 15

    Mar

CENX

Century Aluminum

$14.48

-0.77 (-5.05%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Options
Century Aluminum options imply 12.4% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

ICPT

Intercept

$122.79

-2.66 (-2.12%)

15:19
02/23/17
02/23
15:19
02/23/17
15:19
Recommendations
Intercept analyst commentary  »

Intercept shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 06

    Mar

$NSD

NASDAQ Market Internals

15:18
02/23/17
02/23
15:18
02/23/17
15:18
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:17
02/23/17
02/23
15:17
02/23/17
15:17
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VASC

Vascular Solutions

, TFX

Teleflex

$183.34

-0.67 (-0.36%)

15:16
02/23/17
02/23
15:16
02/23/17
15:16
Hot Stocks
Gabelli liquidates stake in Vascular Solutions »

As a result of the…

VASC

Vascular Solutions

TFX

Teleflex

$183.34

-0.67 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

UPS

UPS

$105.01

-0.615 (-0.58%)

15:12
02/23/17
02/23
15:12
02/23/17
15:12
Hot Stocks
Teamsters says UPS mechanics seek mediation release »

The Teamsters union…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

KMI

Kinder Morgan

15:11
02/23/17
02/23
15:11
02/23/17
15:11
Options
Notable call buying in Kinder Morgan »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$80.74

1.12 (1.41%)

15:06
02/23/17
02/23
15:06
02/23/17
15:06
Hot Stocks
Medtronic reports presentation of data on Solitaire stent retriever »

Medtronic said data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

ACIA

Acacia Communications

$62.22

-4.32 (-6.49%)

15:05
02/23/17
02/23
15:05
02/23/17
15:05
Options
Acacia Communications options imply 14.2% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 04

    Apr

  • 05

    Apr

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:04
02/23/17
02/23
15:04
02/23/17
15:04
Hot Stocks
Harmony Merger receives termination of merger pact from MUNDOmedia »

Harmony Merger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$50.26

-0.08 (-0.16%)

15:02
02/23/17
02/23
15:02
02/23/17
15:02
Hot Stocks
Prologis raises annualized dividend level by 5% to $1.76 per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

FDX

FedEx

$191.42

-2.4099 (-1.24%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Hot Stocks
FedEx extends relationship with Joe Gibbs Racing »

FedEx announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

KATE

Kate Spade

$23.60

-0.24 (-1.01%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Options
In the money call buying in Kate Spade »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$1.80

-0.04 (-2.17%)

15:00
02/23/17
02/23
15:00
02/23/17
15:00
Hot Stocks
Tantech Holdings CEO sees operating profits growing 'substantially faster' »

Tantech Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
02/23/17
02/23
15:00
02/23/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.